PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

Market Cap	9.48B +30.0%
Revenue (ttm)	2.03B +14.8%
Net Income	196.83M -4.4%
EPS	0.91 -12.1%
Shares Out	232.97M
PE Ratio	44.93
Forward PE	40.70
Dividend	0.28 (0.69%)
Ex-Dividend Date	May 30, 2025

Volume	11,431,592
Average Volume	8,724,897
Open	38.12
Previous Close	40.70
Day's Range	38.12 - 40.26
52-Week Range	30.94 - 53.54
Beta	0.65
RSI	59.54
Earnings Date	Apr 22, 2026

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 2,400
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300725

Financial Performance

In 2025, SHE:300725's revenue was 1.97 billion, an increase of 16.93% compared to the previous year's 1.69 billion. Earnings were 183.74 million, a decrease of -16.31%.